Key facts
- Cognishine’s last known valuation is $11.0M (Apr 2025).
- It has raised $3.2M; the latest was Later Stage VC ($2.0M) in Apr 2025.
- Notable investors include EIT Health, Hackaveret, Mind CET.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Cognishine
- ·The full record, as it builds
Funding rounds
No funding rounds for Cognishine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cognishine
Developer of a digital intervention platform designed to transform allied health services with a unified framework. The company's platform integrates tools for synchronous and asynchronous care, customizable treatment plans, and progress tracking across in-person, remote, individual, and group therapy sessions, enabling healthcare organizations and therapists to enhance clinical efficiency, operational flexibility, and patient outcomes.
- Sector
- Healthcare
- HQ
- Lehavim, Israel
- Founded
- 2019
- Employees
- 24
- Website
- cognishine.com/
- Ownership
- Privately Held (backing)
Cognishine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cognishine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cognishine in its N-PORT filings yet. We sweep new filings monthly.